<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Arch Virol (2012) 157:689&#226;&#8364;&#8220;702 <br /> DOI 10.1007/s00705-012-1223-0 <br />  <br />  ORIGINAL ARTICLE <br />  <br />  <br />  <br /> Infection honey bees acute bee paralysis virus does <br /> not trigger humoral cellular immune responses <br /> Klara Azzami &#226;&#8364;&#162; Wolfgang Ritter &#226;&#8364;&#162; Ju&#194;&#168;rgen Tautz           &#226;&#8364;&#162; <br />  <br /> Hildburg Beier <br />  <br />  <br />  <br />  <br /> Received: 21 October 2011 / Accepted: 4 December 2011 / Published online: 19 January 2012 <br /> &#195;&#8220; The Author(s) 2012. This article published open access Springerlink.com <br />  <br />  <br /> <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> We studied responses honey bees              Introduction <br /> different life stages (Apis mellifera) controlled infection <br /> with acute bee paralysis virus identified               Viral infection major burden eukaryotic <br /> haemolymph infected larvae adult worker bees               organisms. As consequence, possess efficient <br /> the compartment massive propagation ABPV                    mechanisms combat viral infections differ ver- <br /> occurs. Insects respond broad spectrum induced             tebrates, insects plants. For example, vertebrates <br /> innate immune reactions bacterial infections,             respond induction cytokines interferon <br /> defence mechanisms based <span id='am-163' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-164' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> play                  family viral RNAs infected cells. Insects lack an <br /> major role antiviral immunity. In study,             adaptive immune system. Instead, rely innate <br /> determined honey bee larvae adult workers            immune system, consisting humoral cellular <br /> produce humoral immune reaction artificial infec-             immune responses, activation prophenoloxidase <br /> tion ABPV, contrast control individuals chal-             serine protease cascade [12, 28, 33, 50]. Infection of <br /> lenged Escherichia coli. ABPV-infected bees                     Drosophila bacteria fungi triggers strong humoral <br /> produced elevated levels specific antimicrobial           response mediated conserved signalling <br /> peptides (AMPs), hymenoptaecin defensin,             cascades, Toll Imd pathways, which <br /> any general antimicrobial activity, revealed inhibi-           regulate transcription target genes conserved <br /> tion-zone assays. Additionally, adult bees did generate          NF-jB-like motifs. Transcription activation results the <br /> melanised nodules ABPV infection, important                  synthesis antimicrobial peptides (AMPs) fat body, <br /> cellular immune function activated bacteria viruses           followed secretion peptides haemolymph. <br /> in insects. Challenge bees ABPV                The cellular immune response mediated circulating <br /> E. coli showed innate humoral cellular immune               cells haemolymph called haemocytes phagocy- <br /> reactions induced mixed infections, albeit               tose encapsulate invading parasites. <br /> reduced level.                                                          The recent sequencing honey bee (Apis mellifera) <br />                                                                      genome [26] revealed honey bees possess homologues <br />                                                                      members Toll Imd pathway implicated in <br /> Electronic supplementary material The online version         humoral immune responses [21]. Moreover, number of <br /> article (doi:10.1007/s00705-012-1223-0) contains supplementary       honey-bee-specific AMPs biochemically character- <br /> material, available authorized users.                    ized Casteels-Josson et al. [11], vivo <br />                                                                      expression confirmed bee larvae adult workers <br /> K. Azzami   J. Tautz   H. Beier (&amp;) <br /> BEEgroup, Biocentre, University Wu&#194;&#168;rzburg,                        bacterial challenge [41]. Although considerable <br /> Am Hubland, 97074, Wu&#194;&#168;rzburg, Germany                                information available humoral defence <br /> e-mail: h.beier@biozentrum.uni-wuerzburg.de                          reactions bees directed bacterial fungal <br />                                                                      infections, antiviral mechanisms social insect not <br /> W. Ritter <br /> Department Bee Pathology, CVUA-Animal Health,                     known all. Studies fruit fly Drosophila in <br /> 79108, Freiburg, Germany                                             mosquitos (Aedes aegypti Anopheles gambiae) have <br />  <br />  <br />                                                                                                                         123 <br />  690                                                                                                          K. Azzami et al. <br />  <br />  <br /> provided convincing evidence intrinsic cell defence      accompanied extreme retardation weight gain and <br /> mechanism based RNA interference plays major role           remarkable change appearance, (ii) ABPV propa- <br /> in antiviral immune responses single-stranded        gation larvae adults monitored observing <br /> double-stranded RNA viruses [3, 23, 29, 44, 51, 53, 54, 57],     viral capsid protein accumulation haemolymph of <br /> whereas reports significance inducible antiviral    infected individuals, (iii) humoral nor <br /> reactions contradictory. Sabatier et al. [43] did    cellular immune responses induced markedly sup- <br /> not detect known AMPs haemolymph            pressed ABPV infection bee larvae adults. <br /> Drosophila flies challenged drosophila C virus (DCV) <br /> (a member family Dicistroviridae). Likewise, injec- <br /> tion cricket paralysis virus (CrPV) haemocoel     Materials methods <br /> adult Drosophila flies did trigger synthesis spe- <br /> cific AMPs known induced Toll       Bacterial strains media <br /> or Imd signalling pathway, indicating absence of <br /> humoral immune reactions dicistroviruses. On          The Gram-negative bacterium Escherichia coli (DSM 682) <br /> the hand, CrPV injected isogenic             obtained Deutsche Sammlung von Mirkoor- <br /> mutants Imd signalling cascade, flies displayed    ganismen Zellkulturen GmbH (DSMZ, Braunschweig), <br /> increased sensitivity CrPV infection higher virus         Gram-positive bacterium Micrococcus flavus a <br /> loads, suggesting Imd pathway involved        gift Dr. U. Rdest (Institute Microbiology, Bio- <br /> antiviral immune response, possibly distinct branches         centre, Wu&#194;&#168;rzburg). The E. coli strain cultivated NB <br /> [15]. Additionally, demonstrated Dostert et al.        medium (5 g <span id='am-2' about='Thesaurus:Nutrient' typeof='owl:Thing'>nutrient</span> broth, 5 g Bacto peptone 10 g <br /> [19] genes controlled JAK/STAT path-         NaCl liter), M. flavus grown LB <br /> way specifically up-regulated DCV infection.           medium (5 g Bacto yeast extract, 10 g Bacto tryptone and <br /> Furthermore, induction Toll pathway          10 g NaCl liter). All ingredients purchased <span id='am-4' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> identified important antiviral response Drosophila      Becton Dickinson (Heidelberg, Germany). For infection <br /> upon infection drosophila X virus [56] Aedes         experiments, E. coli bacteria grown absorbance <br /> aegypti dengue virus infection [55]. More recent studies      A550 = 0.5 (*3 9 108 cells/ml). After centrifugation at <br /> have revealed dual function member Dicer           5200 rpm 5 min (Eppendorf 5417R), cells washed <br /> family. In addition involvement RNA interference,      times resuspended phosphate-buffered saline <br /> the DExD/H-box helicase Dicer-2 shown           (PBS) desired concentration. <br /> regulate induction protein (Vago) controls viral <br /> load tissues Drosophila [16].                         Preparation ABPV suspensions <br />    In report, examined response honey <br /> bee larvae adult workers infection acute bee       A single highly purified virus suspension prepared the <br /> paralysis virus (ABPV). This bee virus originally            CVUA laboratory (Freiburg, Germany) served source <br /> regarded picorna-like virus recently           acute bee paralysis virus (ABPV). For virus propaga- <br /> assigned new family Dicistroviridae [14]. ABPV        tion, ABPV suspension injected haemo- <br /> a single-stranded positive-sense polyadenylated RNA              coel white-eyed worker pupae honey bees (Apis <br /> genome 9.491 nucleotides. The genome consists          mellifera). The infected pupae maintained an <br /> open reading frames (ORFs) separated intergenic            incubator 35&#194;&#176;C 3 days. Thirty bee pupae were <br /> region. ORF1 encodes non-structural proteins helicase,       crushed 40 ml 0.01 M potassium phosphate buffer, <br /> 3C-protease RNA-dependent RNA polymerase,              pH 7.2 (PPB), 2 ml diethyldithiocarbamic acid 1 ml <br /> ORF2 encodes capsid proteins [25; Fig. 1A]. The             chloroform. The mixture passed cotton <br /> structure dicistrovirus capsids shows similarities         gauze, centrifuged 4000 rpm 30 min incubated <br /> vertebrate non-enveloped picornaviruses,           4&#194;&#176;C 16 h. The supernatant centrifuged at <br /> intriguing differences [49]. ABPV discovered           24,000 rpm 4.5 h Beckman SW41 rotor. The <br /> inapparent infection adult bees Bailey et al. [5]. In      precipitated virus resuspended 1 ml PPB, layered <br /> contrast observed low impact ABPV infections        10-40% (w/v) sucrose gradient centrifuged at <br /> the <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span>survival</span> bee colonies years, shortly       21,000 rpm 3 h Beckman SW28 rotor. The virus <br /> the introduction varroa mite (Varroa destructor)       fraction recovered, layered 30-60% (w/v) CsCl <br /> Europe, ABPV linked high mortality colonies        gradient centrifuged 40,000 rpm 18 h a <br /> infested ectoparasite [24].                            Beckman SW41 rotor. The virus-enriched fraction was <br />    Here, (i) bee larvae respond sudden       dialyzed PPB. The concentration ABPV the <br /> deadly collapse artificial infection ABPV,            purified preparation A260 = 5.0, corresponding <span id='am-6' about='protege:TO' typeof='owl:Thing'>to</span> <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                                                       691 <br />  <br />  <br />           A <br />                 IRES                                                                    IGR IRES          I   II         III <br />  <br />                                 helicase         3C-protease            RdRp                      VP1     VP4      VP2         VP3          (A)n <br />          Vpg <br />                  AUG                                                                    UAA AUG                                      UAA <br />                  605                                                                    6325 6509                                    9253 <br />                                                                                                         VP0 <br />  <br />  <br />  <br />  <br />                                         non-structural proteins (ORF1)                            capsid proteins (ORF2) <br />  <br />           B            [kDa] <br />                                            C        [kDa] <br />                                                      200       D <br />                                                      116                                                           * <br />                                                       67          1    MNAAFRNTIP   ADQETNTSNV   HNTQLASTSE   ENSVETEQIT   TFHDVETPNR <br />                        116                                      -51    IDTPMAQDTS   SARSMDDTHS   IIQFLQRPVL   IDHIEVIAGS   TADDNKPLNR <br />                                                                 101    YVLNRQNPQP   FVRSWTLPSV   VLSAGGKGQK   LANFKYLRCD   VRVKIVLNAN <br />                                                      45                                                                                        VP 1 <br />                                                                 151    PFIAGRLYLA   YSPYDDRVDP   ARSILNTSRA   GVTGYPGVEI   DFQLDNSVEM <br />                                                                 201    TIPYASFQEA   YDLVTGTEDF   VKLYLFTITP   ILSPTSTSAS   SKVDLSVYMW <br />                         67 VP 1 (36 kDa)                        251    LDNISLVIPT   YRVNTSIVPN   VRTVVQAVQN   ITTRDSETIR   KAMVALRKNN <br />                            VP 2 (33 kDa)                        301    KSTYDYIVQA   LSSAVPEVKN   VTMQINSKKN   NPNKMATSVK   EKPKSILKPK <br />                                                       29        351    TENPKIGPIS   ELATGVNKVA   NGIERIPVIG   EMAKPVTSTI   KWVADKIGSV          VP 4 <br />                                VP 3 (27 kDa)                    401    AAIFGWSKPR   NLEQVNLYQN   VPGWGYSLYK   GIDNSVPLAF   DPNNELGDLR <br />                         45                                      451    DVFPSGVDEM   AIGYVCGNPA   VKHVLSWNTT   DKVQVPISNG   DDWGGVIPVG <br />                                                       21        501    MPCYSKIIRT   TENETTQTKT   EVMDPAPCEY   VCNMFSYWRA   TMCYRIAIVK <br />                                                                 551    TAFHTGRLEI   FFEPGRIPIT   TTKDNISPDL   TQLDGIKAPS   DNNYKYILDL          VP 2 <br />                                                                 601    TNDTEITIRV   PFVSNKMFMK   STGIYGGNSE   NNWDFSESFT   GFLCIRPVTK <br /> VP 1 (36 kDa)           35                                      651    LMCPETVSNN   VSIVVWKWAE   DVVVVEPKPL   LSGPTQVFQP   PVTSADSINI <br />                                                      14,4 <br /> VP 2 (33 kDa)                                                   701    IDASMQINLA   NKADENVITF   FDSDNAEERN   MEALLKGSGE   QIMNLRSLLR <br />                                                                 751    TFRTISENWN   LPPNTKTAIT   DLTDVADKEG   RDYMSYLSYI   YRFYRGGRRY <br />                                VP 4 (7.5 kDa)        6,5 <br />                                                                 801    KFFNTTALKQ   SQTCYIRSFL   VPRYYTTDNT   NNDGPSHITY   PVLNPVHEVE          VP 3 <br /> VP 3 (27 kDa)                                                   851    VPYYCQYRKL   PVASTTDKGY   DASLMYYSNV   GTNQIVARAG   NDDFTFGWLI <br />                         25 <br />                                                                 901    GTPQTQGITR   TETK <br />  <br />  <br />  <br />  <br /> Fig. 1 Genomic mapping ABPV capsid proteins. (A) Schematic             VP1 VP4. (D) Capsid proteins excised gel, their <br /> diagram genome ABPV, classified dicistro-         peptide composition determined MS/MS analysis in-gel <br /> virus. The numbers represent nucleotide positions according Govan      digestion trypsin. The bracket (*) denotes peptide fragment <br /> et al. [25]. ORF1 encodes helicase, 3C-protease RNA-           derived cleavage VP1 protease V8. The black arrow <br /> dependent-RNA polymerase (RdRp), ORF2 encodes            points presumed translation initiation site [39]. Triangles <br /> capsid proteins. The intergenic region (IGR) ORFs         signify putative cleavage sites capsid precursor [18, 25]. <br /> acts internal ribosomal entry site (IRES). Roman numbers            The amino acid sequence capsid precursor protein shown in <br /> indicate processing sites. A purified ABPV suspension separated       (D) identical ABPV strain &#226;&#8364;&#732;&#226;&#8364;&#732;Germany 2&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> in 10% (B) 15% PAA/0.1% SDS gel (C). The gel stained             (gi|19068035) described Bakonyi et al. [7]. Underlined amino <br /> with Coomassie blue G250. Arrows specify viral capsid proteins        acids indicate variable positions (colour figure online) <br />  <br />  <br />  <br /> 1 mg/ml [6] equivalent 1012 particles/ml                     In vitro rearing worker bee larvae septic <br /> [22]. The A260/A280 ratio 1.7. RT-PCR analysis                        wounding <br /> revealed complete absence sacbrood virus (SBV) <br /> and minor contaminations deformed wing virus                           Larvae collected comb special grafting <br /> (DWV) ABPV preparation.                                            tool transferred 24-well tissue culture plate filled <br />                                                                           300 ll basic diet, consisting 4.2 g freeze-dried <br /> Origin honey bee larvae adults                                     royal jelly powder, 0.6 g fructose, 0.6 g glucose, 0.2 g <br />                                                                           Difco yeast extract 14.4 ml sterile deionised water <br /> During summer seasons 2008 2010, worker honey                   according Peng et al. [40]. The larvae maintained <br /> bee larvae adult bees obtained year                incubator (Memmert, HCP108) 35 &#194;&#176;C 70% <br /> colonies sister queens Apis mellifera carnica                     relative humidity. Each day, transferred new <br /> maintained BEEstation (University Wu&#194;&#168;rzburg).                   tissue culture plates filled fresh nutrients. As deter- <br /> For studies, healthy bee colonies selected                  mined previously, larval weight useful index age <br /> that free chalk brood American foulbrood                  [41]. For artificial infection ABPV E. coli, fourth- <br /> in infestation Varroa mite kept                instar larvae average weight 40-60 mg were <br /> a low level professional beekeeper.                                  employed. The larvae injected dorsally either <br />  <br />  <br />                                                                                                                                             123 <br />  692                                                                                                           K. Azzami et al. <br />  <br />  <br /> 1 ll phosphate-buffered saline (PBS) 1 ll        removed, melanised, darkened nodules were <br /> appropriate amounts E. coli cells ABPV particles     counted stereomicroscope (Olympus SZX7). After <br /> described [41] indicated legend figures.      initial counting, alimentary canal removed, and <br />                                                                nodules remaining internal tissue counted. <br /> In vitro challenge adult bees viruses <br /> and bacteria                                                   SDS polyacrylamide gel electrophoresis <br />  <br /> Freshly emerged bees obtained caged comb           One-dimensional gel electrophoresis carried in <br /> placed incubator 35 &#194;&#176;C 20 days        vertical polyacrylamide slab gels containing 0.1% SDS <br /> deposition eggs queen confined comb       5% stacking gel separation gel [32]. <br /> brood. For series experiments, collected young     Haemolymph samples (1-1.5 ll) diluted 29 <br /> worker bees divided 4 6 groups,        concentrated sample buffer, heated 3 min 95 &#194;&#176;C and <br /> was kept untreated control group. The remaining bees     subjected electrophoresis constant voltage (120 V). <br /> were anesthetized chilling ice, subsequently,        As rule, 10% 15% polyacrylamide gels run in <br /> volumes 1 ll buffer (PBS), bacteria (E. coli) virus   parallel haemolymph samples. For even <br /> (ABPV) injected laterally second      better resolution small proteins, PAGE of <br /> third tergit haemocoel. For injection, disposable     Scha&#194;&#168;gger von Jagow [46] employed some <br /> calibrated (1-5 ll) glass capillaries (Servoprax, Harten-      modifications [41]. After electrophoresis, gels first <br /> stein, Wu&#194;&#168;rzburg) fine tips utilized. The bees    fixed 30 min 0.85% o-phosphoric acid/20% metha- <br /> each group (10 20 individuals) kept small metal     nol followed colloidal Coomassie blue G250 staining <br /> boxes supplied 45% (w/v) sucrose solution           overnight solution Roti&#195;&#8217;-Blue (Roth, Karlsruhe, <br /> incubator 35 &#194;&#176;C haemolymph collection.                Germany) 20% methanol. Gels destained 25% <br />                                                                methanol. <br /> Haemolymph collection <br />                                                                MS analysis protein identification <br /> At indicated times septic aseptic wounding, <br /> all challenged larvae adult bees bled puncturing    Stained protein bands excised gel sub- <br /> the abdomen fine-tipped glass capillary (see above).    jected in-gel digestion trypsin. Protein identification <br /> The collected haemolymph transferred reaction           nano LC-ESI-MS/MS analysis, NCBI nr protein <br /> tubes containing mixtures N-phenylthiourea (PTU)        database search performed Proteome Factory AG, <br /> aprotinin described [41]. The samples kept -20      Berlin, Germany. <br /> &#194;&#176;C analysis. <br />  <br /> Inhibition-zone assay                                          Results <br />  <br /> An aliquot (0.2 ml) fresh overnight bacterial culture     Characterization genomic mapping ABPV <br /> was spread agar plates (&#195;&#732; 9 cm) containing NB LB       capsid proteins <br /> medium. The test bacteria E. coli 682 (Gram- <br /> negative) M. flavus (Gram-positive). As soon         Phylogenetic analysis ABPV strains different geo- <br /> bacterial layer adsorbed, 1.5 ll undiluted         graphic origin RT-PCR assays revealed close <br /> haemolymph samples applied droplet          genetic relationship ABPV samples different <br /> plates pipette tip. After 24 h incubation      European countries [7]. The ABPV strain UK <br /> incubator 37 &#194;&#176;C, clear zones inhibition         (Fig. 1A) employed genome sequence analysis <br /> documented photography dark background.           Govan et al. [25] served reference. First, we <br />                                                                established German origin virus sample used in <br /> Assays nodulation reactions                                studies, confirmed expanded the <br />                                                                genomic mapping ABPV capsid proteins. Separation of <br /> We assessed nodule formation adult bees (ten individ-       virus preparation 10% 15% denaturing <br /> uals group) 6 24 h injection E. coli     polyacrylamide gels revealed total capsid proteins <br /> cells ABPV particles, respectively. A total       approximately 36, 33, 27 7.5 kDa (Fig. 1B, C) that <br /> series experiments carried out. Before analysis,   numbered VP1 VP4 decreasing order their <br /> bees embedded paraffin (Histosec, Merck, Ger-          size [25]. The protein bands excised the <br /> many). The dorsal abdominal tergits carefully             gels characterized true ABPV capsid proteins by <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                                          693 <br />  <br />  <br /> subsequent MS/MS analysis. Figure 1D shows summary                         We determined response newly emerged <br /> of tryptic peptides identified             adult worker bees serial dilutions ABPV sus- <br /> capsid proteins total independent analyses. The             pension application haemocoel. As controls, <br /> amino acid sequences revealed ABPV strain used                  used uninfected bees bees treated with <br /> in studies nearly identical Germany 2 strain               105 viable E. coli cells. We previously shown that <br /> characterized Bakonyi et al. [7]. The N-terminal                      challenge young adult bees (1-2 days old) high <br /> sequences VP2 VP3 recently determined                     dose E. coli cells (i) deleterious effect bees <br /> Edman degradation [25] indicated red blue                 (ii) results pronounced stimulation humoral <br /> arrowheads Fig. 1D. The smallest capsid protein, VP4,                 immune response, deduced expression of <br /> had mapped ORF2 region,                  antimicrobial peptides (AMPs) immune-responsive <br /> tryptic peptide analysis gel-excised VP4 capsid                   proteins [41]. Furthermore, demonstrated Bedick <br /> protein clearly indicated genomic location VP1               et al. [8] newly emerged adult workers respond to <br /> and VP2 (Fig. 1A, D). The cleavage site VP1                  bacterial challenge strong nodule formation, indicat- <br /> VP4 tentatively assigned located pep-                  ing cellular immune reactions activated in <br /> tide sequences VTMQ INSK comparison                          young bees. Almost individuals control <br /> putative cleavage sites related dicistroviruses [18, 52].             groups survived maintenance small cages 48 h, <br /> We unable identify N-terminal sequence                    84% 94%, respectively, alive after <br /> VP1 Edman degradation, possibly VP1                     72 h (Table 1). Dilution ABPV suspension 10-7 <br /> blocked N-terminus. Hence, confirm                     prior injections 1-ll samples (containing *102 virus <br /> initiation translation polyprotein encoded                  particles) did pronounced effect survival <br /> ORF2 starts alanine (position 11, illustrated                  rate pathological symptoms infected bees. <br /> Fig. 1D) suggested authors [9, 18, 30, 39].                They looked healthy prolonged culture times <br /> However, pointed digestion ABPV                 (C96 h). Quite contrast, injection 103 104 virus <br /> capsid protein VP1 protease V8 revealed long                      particles severe impact pathological <br /> peptide N-terminal region VP1, indicating                 effects survival rate infected individuals. None <br /> initiation translation starts upstream glutamate               bees alive 72 h p.i. (Table 1). Bees were <br /> codon position 14 (Fig. 1D).                                          regarded &#226;&#8364;&#732;&#226;&#8364;&#732;dead&#226;&#8364;&#8482;&#226;&#8364;&#8482; motionless had <br />                                                                          turned backs. Symptoms beginning paralysis, <br /> Dose-dependent response bee larvae adults                         i.e., trembling wings bodies affected bees <br /> to ABPV infection                                                        occurred 18 48 h, depending dilution <br />                                                                          ABPV. No bees survived the <br /> In original description ABPV Bailey et al. [5],                application *104 ABPV particles, 60% were <br /> adult honey bees challenged virus                 alive 48 h infection *103 virus particles <br /> different ways, i.e., feeding, spraying, artificial               (Table 1). <br /> injection ABPV suspension. The LD50 (number                         Next, studied response fourth-instar larvae to <br /> ABPV particles bee killed half                ABPV infection. At developmental stage, i.e., four <br /> bees group 6 days) equivalent 102                days hatching, bee larvae average weight of <br /> when preparations injected haemocoel com-                  30 40 mg survive aseptic septic wounding a <br /> pared 1011 particles bee feeding                 great extent [41]. As shown Table 2, injection 105 <br /> 108 109 particles bee spraying, indicating high            E. coli cells resulted 80 90% survival bee larvae <br /> virulence ABPV injection.                                        24 h p.i. A similar survival rate observed larvae <br />  <br /> Table 1 Survival [%] newly emerged adult worker bees artificial infection E. coli ABPV <br /> Time (h) p.i.              Uninfecteda            E. colia 105 cells            ABPVa <br />                                                                                 104   b <br />                                                                                                           103   b <br />                                                                                                                             102   b <br />  <br />  <br /> 24                         100 &#194;&#177; 0                  99 &#194;&#177; 1.7                    54.3 &#194;&#177; 27.7               82.7 &#194;&#177; 30         98.3 &#194;&#177; 2.9 <br /> 48                         100 &#194;&#177; 0                95.3 &#194;&#177; 4.5                    6.3 &#194;&#177; 6.5                 56.7 &#194;&#177; 24.5       95.3 &#194;&#177; 4.5 <br /> 72                         93.7 &#194;&#177; 3.2             83.7 &#194;&#177; 3.8                    0                         0                  91 &#194;&#177; 6.6 <br /> Each group consisted originally 25 individuals kept small cages incubator 35 &#194;&#176;C <br /> a <br />     The results mean &#194;&#177; standard deviation (SD) independent series experiments <br /> b <br />     Number injected ABPV particles bee <br />  <br />  <br />                                                                                                                            123 <br />  694                                                                                                                     K. Azzami et al. <br />  <br />  <br /> Table 2 Survival (%) fourth-instar bee larvae 24 h post-injection E. coli ABPV <br /> Series experiment               Uninfected              E. coli 105 cells          ABPV <br />                                                                                       103   b <br />                                                                                                         102   b <br />                                                                                                                               101   b <br />  <br />  <br /> I (2008)                           100 (14/14)a            80 (12/15)                 0 (0/12)          53 (8/15)             81 (13/16) <br /> II (2008)                          91 (10/11)              83 (10/12)                 0 (0/17)          39 (7/18)             75 (15/20) <br /> III (2009)                         100 (12/12)             90 (9/10)                  0 (0/22)          50 (6/12)             91 (10/11) <br /> Mean &#194;&#177; SD                          97 &#194;&#177; 5.2                84.3 &#194;&#177; 5.1                 0                 47.3 &#194;&#177; 7.4            82.3 &#194;&#177; 8.1 <br /> a <br />     Number survivors relation total number individuals <br /> b <br />     Number injected ABPV particles larva <br />  <br />  <br /> were challenged 101 ABPV particles larva.                        VP4. This feature explains did detect <br /> No larvae survived injections *103 ABPV particles,                     visible amounts VP4 15% PAA gels (not shown). MS/ <br /> whereas 50% larvae alive 24 h injection               MS analysis VP1/VP4 precursor revealed exclu- <br /> of *102 ABPV particles.                                                   sively VP1-derived peptides (up 31% sequence cover- <br />                                                                           age) analyses, VP4-specific peptide <br /> ABPV accumulates haemolymph bee larvae                          IGSVAAIFG, peptides originating VP2 or <br /> and adults                                                                VP3. The ABPV-derived capsid proteins be <br />                                                                           detected 12 h p.i. individuals challenged with <br /> Young adult worker bees injected relatively small                    *104 particles clearly visible 18 h 24 h p.i. <br /> doses ABPV (approximately 103 virus particles bee)                 bees infected 103 104 ABPV particles <br /> developed signs trembling paralysis early              (Fig. 2A), corresponding signs pathological <br /> 18 h post-injection died days later                        effects infected bees (Fig. 2B). At prolonged incubation <br /> (Table 1). We studied time course virus                       times, sick bees extremely desiccated it <br /> propagation collecting haemolymph samples adult                   impossible collect sufficient haemolymph samples <br /> bees different times post-injection different                     protein analysis. Another picture emerged if <br /> amounts ABPV particles analysed total                     worker bees challenged 102 ABPV parti- <br /> protein patterns SDS-PAGE. In newly emerged worker                     cles. The haemolymph protein <span id='am-241' about='xsp:pattern' typeof='owl:Thing'>pattern</span> remained essentially <br /> bees (1-2 days old), apolipophorin (ApoLp)-I -II (the                 constant 96 h p.i., virus-specific capsid proteins <br /> latter lacking N-terminal amino acids 1 747),                      detected (Fig. 2C), correlating high <br /> transferrin imaginal disc growth factor 4 (IDGF-4)                survival rate infected bees (Fig. 2D). <br /> prominent haemolymph proteins, expression                          The time course ABPV multiplication also <br /> vitellogenin low early developmental stage               studied haemolymph samples infected bee larvae <br /> [41]. Upon infection ABPV, little change                      6 24 h p.i. The haemolymph protein pattern of <br /> overall protein pattern observed 6 24 h                   fourth- fifth-instar larvae differs considerably that <br /> p.i. compared haemolymph samples derived                       young adult bees: addition ApoLp-I/ ApoLp-II and <br /> uninfected mock-infected (PBS) individuals,                  transferrin, classes hexamerins (i.e., hexamerin 110, <br /> exception novel major proteins present              hexamerin 70a, hexamerin 70b hexamerin 70c) a <br /> approximately equal amounts visible                      very-high-density lipoprotein (VHDL) constitute bulk <br /> samples collected ABPV-infected bees. The migra-                     larval haemolymph proteins [41]. Upon infection with <br /> tion coincided ABPV capsid                       *103 ABPV particles larva, capsid proteins <br /> proteins VP2 VP3, migrated                      VP1/VP4, VP2 VP3 detected simultaneously in <br /> more slowly expected capsid protein VP1                          haemolymph infected larvae early 9 h p.i., and <br /> (Fig. 2A). We eluted corresponding protein bands                 production increased 24 h p.i. No virus-specific <br /> the gel confirmed viral origin VP2 VP3                  capsid proteins visible larvae infected only <br /> subsequent MS/MS analysis. The amino acid sequence                        101 ABPV particles (Fig. 3A), correlates with <br /> coverage ranged 27% (VP2) 61% (VP3)                       healthy appearance larvae high survival <br /> viral capsid proteins. Significant amounts bee-specific                rate (Fig. 3B, C). Uninfected larvae larvae challenged <br /> proteins migrated position similar VP3               101 ABPV particles gained weight 45 mg <br /> were identified ferritin 1 (gi|110762641) ferritin 2               time injection (i.e., fourth instar stage) about <br /> (gi|66524161). The virus-specific protein char-                 95 mg larva haemolymph collection 24 h p.i. <br /> acterized precursor capsid protein composed VP1                   (Fig. 3B). Quite image emerged larvae were <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                                                                                           695 <br />  <br />  <br />       A                        6 h p.i.                        12 h p.i.                       18 h p.i.             24 h p.i.                 B <br />                                ABPV       ABPV                   ABPV      ABPV                     ABPV ABPV         ABPV ABPV                                  ABPV 102 <br />                     n.i. PBS 104              103     n.i. PBS 104          103    [kDa] n.i. PBS    104    103 n.i. PBS 104 103 ABPV         [kDa] 24 h       48 h   72 h   96 h p.i. ABPV <br />     ApoLp-I <br /> Vitellogenin                                                                        116                                                        116 <br />    ApoLp-II <br />                                                                                     67                                                         67 <br />  Transferrin <br />     IDGF-4                                                                          45                                                         45 <br />  <br />                                                           VP 1/4                    35                                                 VP 1    35 <br />                                                            VP 2                                                                        VP 2 <br />                                                            VP 3                     25                                                 VP 3    25 <br />  <br />  <br />                    1     2     3   4      5    6      7    8     9 10      11 12    L     13 14 15 16 17 18 19 20 21 22 23 <br />                                                                                                                                                      Time [h] p.i.     ABPV 102 <br />  <br />                Time [h] p.i.                   n.i.                         PBS                      ABPV 104             ABPV 103                        24          100 (24/24) <br />                                                                                                                                                           48           95 (19/20) <br />                      6                    100 (31/31)                   100 (27/27)                 100 (23/23)          100 (27/27)                      72          100 (13/13) <br />                     12                    100 (26/26)                   100 (22/22)                 100 (18/18)          100 (22/22)                      96            89 (8/9) <br />                     18                    100 (21/21)                   100 (17/17)                  77 (10/13)           71 (12/17) <br />                     24                    100 (16/16)                   100 (12/12)                   25 (2/8)             42 (5/12) <br />  <br /> Fig. 2 Time course ABPV multiplication haemolymph                                              concentration 5 lg/ll. Newly synthesized ABPV-specific capsid <br /> infected adult worker bees. Newly emerged worker bees (1-2 days                                             proteins indicated red arrowheads. As control, aliquot of <br /> old) kept untreated (n.i.), mock-infected PBS                                           7 ll undiluted ABPV suspension (1 mg/ml; *1012 virus <br /> challenged 102, 103 104 ABPV particles. Haemolymph                                                  particles/ml) loaded gel. The survival rate (%) ABPV- <br /> samples collected 6 24 h p.i. (A) 24                                        infected adult bees monitored short-time (A) and <br /> 96 h p.i. (B) total individuals (replicates) group                                       long-time (B) experiment. The numbers brackets represent the <br /> followed protein analysis inhibition-zone assays. The analyses                                       number survivors relation total number individuals. The <br /> of 1-2 replicates shown. Aliquots 1.5 ll (out *8 ll)                                         total number bees decreased prolonged incubation times <br /> applied 10% PAA/0.1% SDS gel, 1.5-ll aliquots                                          individuals removed group the <br /> sample applied directly agar plates M. flavus                                      indicated times (p.i.) subsequent protein inhibition-zone <br /> indicator bacteria. As positive control, lysozyme (L) used                                       assays (colour figure online) <br />  <br />  <br /> challenged *103 ABPV particles. All                                                       challenge E. coli, documented transient <br /> dead 24 h p.i. (Fig. 3B) exhibited severe weight                                                   synthesis antimicrobial peptides (AMPs) <br /> retardation (49 &#194;&#177; 5.7 mg larva) combined                                                         hymenoptaecin, defensin1 abaecin [41]. In present <br /> change colour yellowish-white (Fig. 3B, larvae 13                                                   study, compared reactions bee larvae and <br /> and 18) brownish-black (Fig. 3B, larvae 12 17)                                                    adults single infections E. coli ABPV. <br /> compared healthy control larvae. The haemolymph                                                             Fourth-instar larvae divided groups, each <br /> protein pattern likewise changed dramatically. Up 12 h                                                   consisting individuals: group left untreated <br /> p.i., remained unaltered ABPV                                                        (n.i.), group mock-infected (PBS), group was <br /> already multiplied great extent, thereafter,                                                     challenged 105 viable E. coli cells, fourth <br /> striking change overall protein composition                                                 group artificially infected *103 ABPV particles. <br /> observed: proteins related translation,                                                    All larvae kept tissue culture plates filled fresh <br /> energy metabolism, antioxidant protection stress                                                         nutrients incubator 35 &#194;&#176;C 24 h. At time, the <br /> response (Table S1) induced up-regulated                                                        haemolymph collected, aliquots same <br /> (Fig. 3A, lane 18). Finally, larval collapse accompa-                                                   sample employed protein analysis inhibition- <br /> nied complete degradation major                                                         zone assays. As expected, known AMPs, i.e., <br /> haemolymph proteins, hexamerin 70a hex-                                                         hymenoptaecin, defensin1 abaecin, induced in <br /> amerin 70b (Fig. 3A, lane 17; Table S1).                                                                    bee larvae bacterial infection; however, these <br />                                                                                                             AMPs expressed challenge *103 ABPV <br /> Humoral immune response induced bee larvae                                                        particles, visualized 15% PAA / 0.1% SDS gels <br /> or adults ABPV infection                                                                               (Fig. 4A). Proteins apparent similar size hymenop- <br />                                                                                                             taecin eluted gel (lane 8; no. 11), sub- <br /> We previously studied defence reactions honey                                                   sequent MS/MS analysis revealed absence of <br /> bee larvae adults bacterial infections                                                      hymenoptaecin presence newly induced <br /> presented evidence insects develop-                                                   proteins annotated heat shock protein 10 kD thio- <br /> mental stages respond pronounced humoral reaction                                                    redoxin-2 (Table S1). In addition, presence absence <br />  <br />  <br />                                                                                                                                                                               123 <br />  696                                                                                                                                                                                                           K. Azzami et al. <br />  <br />  <br />  A                  6 h p.i.                         9 h p.i.                              12 h p.i.                      24 h p.i. <br />                 ABPV ABPV                           ABPV        ABPV                       ABPV     ABPV                    ABPV       ABPV                                B <br />  [kDa] n.i.         103        101           n.i.    103          101        ABPV n.i.      103        101   n.i.              103         101       ABPV                             n.i.          ABPV 103       ABPV 101 <br />  <br />                                                                                                                                                             ApoLp-I <br />                                                                                                                                                             VHDL                  1 <br />  116                                                                                                                                                                       6h                                       4 <br />                                                                                                                                                             Hex 110                                  2 <br />                                                                                                                      1                                                                                        3               5 <br />                                                                                                                                                             ApoLp-II <br />  67                                                                                                                  2 <br />                                                                                                                      3                                      Transferrin/          81 &#194;&#177; 2.4           56 &#194;&#177; 4.7       68 &#194;&#177; 2.9 <br />                                                                                                                      4                                      Hex 70a <br />                                                                                                                      5 <br />  45                                                                                                                                                         Hex70b/70c <br />                                                                                                                      6                                      IDGF-4                           11                     15 <br />                                          VP 1/4                                                                      7                                                     12 h <br />  35                                                                                                                                                         VP 1 <br />                                           VP 2                                                                      VP 1                                    VP 2                                    12     13      14 <br />                                                                                                                      8 <br />  <br />                                               VP 3                                                                    9                                     VP 3 <br />  25                                                                                                                                                                               79 &#194;&#177; 11            42 &#194;&#177; 8.3       77 &#194;&#177; 5.3 <br />                                                                                                                      10 <br />         1       2        3   4       5       6      7      8      9     10       L   11   12 13 14 15 16                       17 18       19 20 <br />                                                                                                                                                                                    16 <br />                                                                                                                                                                            24 h                               17 <br />                                                                                                                                                                                                      18                  19 <br />               Time [h] p.i.                                n.i.                            ABPV    103                     ABPV      101 <br />                                                                                                                                                                                   95 &#194;&#177; 2.6           49 &#194;&#177; 5.7       92 &#194;&#177; 2.5 <br />                      6                              100        (14/14)                    100    (28/28)                  96    (26/27) <br />                      9                              100        (11/11)                    100    (25/25)                  96    (23/24) <br />                      12                              89         (8/9)                      33    (7/21)                   80    (16/20) <br />                      24                              83         (5/6)                      0    (0/17)                    75    (12/16) <br />  <br /> Fig. 3 Time course ABPV multiplication haemolymph                                                                 weight (mg) expressed mean &#194;&#177; standard deviation 3 4 <br /> infected bee larvae. Fourth-instar larvae left untreated                                                           larvae. Red Arabic numerals indicate larvae selected analysis <br /> (n.i.) challenged 101 103 ABPV particles. Haemolymph                                                                shown (A). Dead larvae indicated red arrows. Black Arabic <br /> samples collected 6 24 h p.i. total 3 4                                                          numerals (sample 17 A) signify protein bands excised. <br /> individual larvae group, followed protein analyses                                                                  The proteins identified MS/MS analysis listed Table S1. The <br /> inhibition-zone assays. The analyses 1-2 replicates shown                                                               survival rate (%) ABPV-infected larvae monitored throughout <br /> (A). Aliquots 1 ll (out *20 ll) applied 10% PAA/                                                               incubation time. The numbers brackets represent number of <br /> 0.1% SDS gel, 1.5 ll sample applied directly                                                            survivors relation total number individuals. The total <br /> agar plates M. flavus indicator bacteria. Newly                                                               number larvae decreased prolonged incubation times because <br /> synthesized ABPV-specific capsid proteins indicated red                                                                 3 4 individuals removed group indicated <br /> arrowheads. The development non-infected (n.i.) ABPV-                                                                   times (p.i.) subsequent analysis (colour figure online) <br /> infected vitro cultured larvae 24 h p.i. shown (B). Larval <br />  <br />  <br />  A                                                                                                                          B <br />                                      24 h p.i.                                                                                                                     24 h p.i. <br />  <br /> [kDa]         n.i.               PBS             E. c. 105              ABPV 103                                               [kDa]        n.i.       PBS         E. c. 105                      ABPV 103 ABPV <br />   97                                                                                       Hex 110                                                                                                                  ApoLp-II <br />                                                                                                                                 97 <br />   68                                                                                       Transferrin/Hex 70a                                                                                                      Transferrin <br />                                                                                                                                 68 <br />   45                                                                                       Hex 70b/70c                                                                            CE-1                              IDGF-4 <br />                                                                                                                                 45 <br />                                                                                           VP 1/4 <br />   29                                                                                      VP 2                                                                                      VP 1/4                         VP 1 <br />                                                                                           VP 3                                                                                    IRp30                            VP 2 <br />                                                                                                                                 29 <br />    21                                                                                                                                                                                                              VP 3 <br />  <br />  12.5                                                                                     FABP/OBP14                            21                                                PGRP <br />                                                                                           11 <br />   6.5                                                                 H <br />                                                                                           VP 4 <br />                                                                       D                                                      12.5                                                                                   OBP 14 <br />   3.5                                                                 A                                                                                                           H                                 ASP3c <br />                                                                                                                                6.5 <br />                                                                                                                                                                                   D <br />    L        1        2           3       4          5      6                 7       8                                         L       1         2     3      4        5   6                        7     8 <br />  <br />  <br />  <br />  <br /> Fig. 4 Comparison humoral immune responses bee larvae                                                                    agar plates M. flavus indicator bacteria. Newly <br /> and adults bacterial viral infections. Fourth-instar larvae                                                           synthesized ABPV-specific capsid proteins indicated red <br /> (A) newly emerged worker bees (B) left untreated                                                                arrowheads. The AMPs hymenoptaecin (H), defensin 1 (D), abaecin <br /> (n.i.), mock-infected PBS, challenged 105 E. coli cells                                                        (A) immune-responsive proteins carboxylesterase (CE-1), <br /> with 103 ABPV particles. Haemolymph samples collected 24 h                                                                IRp30 peptidoglycan recognition protein-S2 (PGRP) induced <br /> p.i., followed protein analysis inhibition-zone assays. Aliquots                                                        bacterial infection [41] marked red arrows. The <br /> of 1.5 ll applied 15% PAA/0.1% SDS gels containing tricine                                                             corresponding bands excised gels, proteins <br /> (A) tricine (B). Aliquots samples applied                                                            identified subsequent MS/MS analysis (colour figure online) <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                              697 <br />  <br />  <br /> of AMPs haemolymph samples evaluated               Challenge young adult worker bees ABPV does <br /> inhibition-zone assay. Employing M. flavus Gram-              evoke nodulation reactions <br /> positive test bacteria revealed antimicrobial activity in <br /> the haemolymph collected uninfected ABPV-                Nodulation cellular immune reaction bacterial <br /> infected larvae, large inhibition zones developed        infection insects involves interactions <br /> after application samples (no. 5 6) derived          circulating haemocytes bacteria [27] is <br /> larvae challenged E. coli (Fig. 4A). Similar results        involved responses viral infections [10, 20]. <br /> were obtained Gram-negative E. coli used          It recently demonstrated Bedick et al. [8] this <br /> test bacteria inhibition-zone assay (not shown). It       specialized cellular defence reaction expressed newly <br /> should noted aseptic wounding PBS         emerged worker bees artificially infected freeze-dried <br /> resulted weak transient synthesis AMPs, described       bacteria (i.e., Serratia marcescens). We similar <br /> previously [41].                                                 observations adult bees challenged viable E. coli <br />    Next, compared response adult bees single        cells bee larvae responded bacterial <br /> infections E. coli ABPV. Newly emerged worker           infection weak nodulation reaction (unpub- <br /> bees likewise divided groups, consisting    lished observation). We injected E. coli cells the <br /> 20 individuals. They kept small cages placed      haemocoel young adult workers assessed for- <br /> an incubator 35&#194;&#176;C artificial infection. Haemolymph      mation nodules selected times post-injection. The first <br /> samples collected 24 h p.i. utilized proteome       melanised nodules visible 2 h p.i., reached a <br /> analysis inhibition-zone assays. Adult bees reacted       maximum approximately 100 nodules bee 6 h p.i., <br /> challenge 105 E. coli cells synthesis       thereafter, total number visible nodules <br /> known AMPs hymenoptaecin defensin1, seen           remained constant 48 h p.i. Figure 5A shows a <br /> corresponding haemolymph samples separated 15%              typical image nodule formation 24 h injection of <br /> PAA/0.1% SDS gel (Fig. 4B). It mentioned          104 viable E. coli cells. It seen abdominal <br /> abaecin visible particular gel. In haemo-     tergites removed haemocoel exposed. <br /> lymph adult bees, chemosensory protein ASP3c           Most melanised nodules attached dorsal <br /> present individuals. Since co-migrates   vessel tracheal system. However, inde- <br /> same position hymenoptaecin (Fig. 4B, lanes 7 8),      pendent series experiments, did observe any <br /> excised corresponding protein bands confirmed        nodules time post-injection 103 104 ABPV <br /> absence induced hymenoptaecin ABPV infection          particles haemocoel freshly emerged worker <br /> subsequent MS/MS analysis. Furthermore, large              bees (Fig. 5B), suggesting cellular defence reac- <br /> immune-responsive proteins up-regulated injec-         tion mediated ABPV bees. <br /> tion bacteria and, occasionally, buffer. The three <br /> proteins identified previously peptidoglycan rec-        Innate immune responses expressed bees <br /> ognition protein-S2 (PGRP-S2), member carboxy-          simultaneously infected ABPV E. coli <br /> lesterase family (CE-1), novel leucine-rich repeat <br /> protein termed IRp30 [1, 41]. None small antimicro-       As reported above, prominent humoral immune response <br /> bial peptides large immune-responsive proteins            induced bee larvae adults ABPV <br /> induced adult bees challenge 103 ABPV par-         infection (Figs. 2, 3, 4), did adult worker bees respond <br /> ticles. Instead, new components expressed large    nodulation reaction challenge ABPV <br /> extent ABPV-infected bees ABPV-specific              (Fig. 5B). Hence, asked question innate <br /> capsid proteins VP1/VP4, VP2 VP3. The overall                immune responses generally suppressed infected <br /> absence AMPs adult bees 24 h ABPV infection          individuals consequence ABPV propagation. We <br /> was confirmed inhibition-zone assay (Fig. 4B)      carried series experiments bee larvae and <br /> time course experiments shown (Fig. 2A). In contrast       adults challenged E. coli ABPV both <br /> to larval haemolymph, samples originating adult bees        pathogens (Fig. 6). <br /> sometimes resulted inhibition zones looked brownish         AMPs induced E. coli infection larvae as <br /> in area sample applied agar plate       early 6 h p.i. (not shown). Longer incubation times 12 <br /> (e.g., Fig. 4B, sample 8) clearly distinguished     24 h p.i. resulted enhanced expression antimi- <br /> from &#226;&#8364;&#732;&#226;&#8364;&#732;positive&#226;&#8364;&#8482;&#226;&#8364;&#8482; controls (e.g., Fig. 4B, samples 5 6).     crobial activity deduced increased production of <br /> The dark staining possibly results production        hymenoptaecin defensin1 enlargement of <br /> melanin. Phenoloxidase inhibitors phenylthiourea         inhibition zones (Fig. 6A). No evidence production <br /> and aprotinin added collected haemolymph samples          AMPs detected ABPV-infected larvae any <br /> had significant effect phenomenon.                    time post-injection (Figs. 3A, 6A). Simultaneous infections <br />  <br />  <br />                                                                                                                    123 <br />  698                                                                                                                           K. Azzami et al. <br />  <br />  <br />                    A <br />  <br />  <br />                                                                 Dorsal vessel <br />  <br />  <br />  <br />  <br />                                                  1000 &#194;&#181;m                                                          500 &#194;&#181;m <br />  <br />  <br />  <br />                    B <br />  <br />  <br />                                                                       Trachea <br />  <br />  <br />  <br />  <br />                                                  1000 &#194;&#181;m                                                          500 &#194;&#181;m <br />  <br />  <br />  <br />                    C <br />  <br />  <br />  <br />  <br />                                                   1000 &#194;&#181;m                                                          500 &#194;&#181;m <br />  <br />  <br /> Fig. 5 Comparison cellular immune responses adult worker             haemocoel inspected presence melanised nodules, <br /> bees bacterial viral infections. Newly emerged worker             indicated red arrows. The average number nodules was <br /> bees challenged 104 viable E. coli cells (A), 103 ABPV           108 &#194;&#177; 14 (A), 0 (B) 52 &#194;&#177; 24 (C), respectively, expressed the <br /> particles (B), mixture pathogenic components          mean &#194;&#177; standard deviation examined bees. Photomicrographs <br /> consisting 104 E. coli cells 103 ABPV particles (C). Groups      Olympus SZX7 stereomicroscope equipped with <br /> 10 individuals kept small cages 24 h p.i. incubator   Olympus UC30 camera. Magnification 259 complete <br /> 35 &#194;&#176;C. Then, abdominal tergites bees removed,      abdomen 759 detailed view (colour figure online) <br />  <br />  <br />  <br /> of larvae E. coli ABPV did suppress                       lanes 15 16), onset visible virus propagation <br /> induction humoral response 12 h p.i., indi-                  delayed mixed infections. <br /> cated presence AMPs inhibition-zone assay                    Simultaneous infections newly emerged adult worker <br /> (Fig. 6A, samples 7-9). However, little antimicrobial                 bees 103 ABPV particles 104 E. coli cells revealed <br /> activity detected mixed infections prolonged                features similar identical those <br /> incubation times 24 h p.i. (Fig. 6A, samples 15                  observed larvae. We did detect reduction the <br /> 16). These observations repeatedly total                 overall antimicrobial activity inhibition-zone assay <br /> three independent series experiments. Multiplication                 24 h p.i. (Fig. 6B, samples 6 7), did <br /> ABPV larvae simultaneous E. coli infection                   observe delay ABPV propagation (Fig. 6B). A slightly <br /> proceeds single infections, revealed massive               different picture emerged injected 104 ABPV parti- <br /> production ABPV-specific capsid proteins (Fig. 6A,                      cles 105 E. coli cells simultaneously young adult <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                                                                                                699 <br />  <br />  <br />       A                                                                                                                     B <br />                                      12 h p.i.                                           24 h p.i.                                                      24 h p.i <br />                        E. coli           ABPV         E.c. 104 +               E. coli        ABPV    E.c. 104 +                              E. coli              ABPV      E.c. 104 + <br />           ABPV n.i.       104             103         ABPV 103         n.i.     104            103    ABPV 103 [kDa]        ABPV       n.i.    104                   103     ABPV 103 [kDa] <br />                                                                                                                    97                                                                      97 <br />                                                                                                                    67                                                                      67 <br />                                                                                                                    45                                                                      45 <br />      VP1               VP 1/4                                                                                             VP1                            VP 1/4 <br />      VP2                 VP2                                                                                       29     VP2                              VP2                             29 <br />      VP3                                                                                                                  VP3 <br />                           VP3                                                                                                                                VP3 <br />                                                                                                                    21                                                                      21 <br />  <br />                                                                                                                    12.5                                                                    12.5 <br /> OBP 14 <br />                                  H                                 H                      H                        6.5                                   H                   H <br />                                                                                                                                                                                            6.5 <br />                                                                                           D                                                              D                   D <br />  <br />  <br />                  1    2     3        4     5      6   7   8    9       10      11 12          13 14    15 16        L              1      2    3   4                  5          6   7 <br />  <br />  <br />  <br />              100        100                50           80              100       80            0       0                         100            100                 85            100 <br />            (10/10)    (10/10)            (5/10)       (8/10)           (5/5)     (4/5)        (0/5)   (0/5)                     (30/30)        (17/17)             (33/39)       (16/16) <br />  <br />  <br /> Fig. 6 Responses bee larvae adults simultaneous                                            Haemolymph samples collected indicated times, followed <br /> infection E. coli ABPV. Fourth-instar larvae (A) newly                                    protein analysis inhibition-zone assays. Survival rates [%] are <br /> emerged worker bees (B) left untreated (n.i.), challenged                                         indicated below. Newly synthesized ABPV-specific capsid proteins <br /> separately 104 E. coli cells 103 ABPV particles                                       indicated arrowheads. H = hymenoptaecin, D = defensin1 <br /> challenged mixture 104 E. coli cells 103 ABPV particles. <br />  <br /> worker bees. Under experimental conditions, did                                               propagation able monitor virus multiplication in <br /> not observe delay ABPV propagation, did                                                    vivo natural host observing capsid protein synthesis <br /> observe reduction antimicrobial activity (not shown).                                             gel electrophoretic analysis (Figs. 2A, 3A). The trans- <br />    As shown above, adult worker bees responded                                                lation ORF2 internal ribosomal entry site <br /> formation nodules E. coli infection (Fig. 5A),                                                 (Fig. 1A) yields precursor polypeptide *104 kDa <br /> whereas reaction initiated ABPV infec-                                              (Fig. 1D) processed functional capsid <br /> tion (Fig. 5B). Simultaneous injection E. coli ABPV                                             units proteolytic steps (indicated I, II III in <br /> into haemocoel young worker bees did suppress                                               Fig. 1A), (I III) likely generated <br /> the nodulation reaction completely resulted                                                   virus-encoded 3C protease. This chymotrypsin-like <br /> reduced number nodules detected 24 h p.i. (Fig. 5C).                                             cysteine protease cleaves right conserved glutamine <br />                                                                                                        (Q) residue [18, 42]. The structural motif third <br />                                                                                                        cleavage site separating VP4 VP2 (cleavage site II) is <br /> Discussion                                                                                             highly conserved dicistroviruses [52]. Yet, corre- <br />                                                                                                        sponding proteolytic activity known. It been <br /> In connection recent expansion ectoparasitic                                           proposed site processed autocatalytically inside <br /> mite Varroa destructor honey bee colonies, newly                                                  mature virion [34, 49] unknown host-cell <br /> acquired virulence bee viruses belonging                                             activity involved. We detected single precursor <br /> family Dicistroviridae observed worldwide [24].                                               polypeptide ABPV-infected bee larvae adults is <br /> We focused acute bee paralysis virus                                              composed VP1 VP4 designated VP0 <br /> (ABPV), 18 bee viruses identified far [2, 13].                                         (Fig. 1A) analogy picornaviruses [31]. This capsid <br /> ABPV shares antigenic sequence similarities                                              precursor expressed time about <br /> Kashmir bee virus (KBV) Israeli acute paralysis virus                                              equivalent amounts capsid protein units VP2 and <br /> (IAPV), form distinct subgroup                                              VP3 (Figs. 2A, 3A), indicating simultaneous cleav- <br /> the family Dicistroviridae [9, 17, 18, 35]. Three major                                                ages polyprotein precursor processing sites II and <br /> features general relevance concerning viral infections:                                         III. Infrequently, observed separate capsid protein <br /> (i) site viral propagation infected individuals,                                         units VP1 VP4 ABPV-infected larvae 24 h p.i. <br /> (ii) routes viral transmission, (iii) defence                                           (Figs. 3A, 4A), implying processing step I late <br /> mechanisms initiated viral infection.                                                             event. This processing scheme observed vivo the <br />     We identified haemolymph infected bee lar-                                             haemolymph ABPV-infected bees differs that <br /> vae adults source massive ABPV                                                        suggested Tate et al. [49], determined first <br />  <br />  <br />                                                                                                                                                                                      123 <br />  700                                                                                                               K. Azzami et al. <br />  <br />  <br /> three-dimensional crystal structure insect picornavirus      adult bees (Figs. 2A, 3A). If excludes possibility that <br /> (i.e., cricket paralysis virus, CrPV) indicated order   aberrant virus particles released great extent any <br /> capsid proteins encoded precursor VP2/VP4/VP3/           cell type, haemocytes remain likely candidates <br /> VP1. This numbering appears misleading,           ABPV propagation. In adult bees acutely infected with <br /> reflects order capsid proteins picornaviruses    ABPV, virus accumulates brain hypopharyn- <br /> (VP4/VP2/VP3/VP1), numbers 1 4 refer               geal glands [4]. Since haemolymph circulates freely <br /> poliovirus capsid proteins order decreasing size [31],       body sections honey bee, ABPV could <br /> nor actual sizes CrPV capsid proteins        reach head abdominal infections means: <br /> result genomic order VP2/VP4/VP1/VP3 (AF218039;             entrapped haemocytes free virus <br /> 35). Tate et al. [49] proposed cleavage site II       particles release disintegrating cells. <br /> most likely occurs concurrently packaging viral           Challenge insects microorganisms induces cel- <br /> RNA mature virus particle        lular humoral immune responses. Nodulation cel- <br /> C-terminus VP4 located close proximity          lular immune function activated bacteria fungi <br /> N-terminus VP3, i.e., &#226;&#8364;&#732;&#226;&#8364;&#732;bonding&#226;&#8364;&#8482;&#226;&#8364;&#8482; distance. There        [48], shown reaction involved <br /> are reports support assumption cleavage      responses viral infections. For example, larvae of <br /> site II late processing event, studies          endoparasitoid Pimpla turionella (Hymenoptera) and <br /> present data instead indicate cleavage site I         larvae greater wax moth Galleria mellonella (Lepi- <br /> occurs late infection. N-terminal sequencing capsid          doptera) challenged bovine herpes simplex virus-1 <br /> proteins obtained purified immature Plautia stali             (BHSV-1) induced nodulation reactions dose-dependent <br /> intestine virus (PsIV) particles revealed minor pre-        manner [10, 20]. Newly emerged adult bees responded a <br /> cursor protein 35 kDa called VP0 N-ter-            pronounced production melanised nodules E. coli <br /> minal sequence VP4, suggesting VP0 composed          infection (Fig. 5A); however, nodules detected <br /> VP4 VP2 according numbering PsIV [38, 45].           ABPV infection (Fig. 5B), suggesting type of <br /> On hand, studies propagation CrPV          cellular immune response activated ABPV in <br /> drosophila C virus (DCV) Drosophila cells revealed            bees. Moreover, data indicate honey bee larvae and <br /> pattern similar observed multiplication         adults trigger general humoral immune <br /> ABPV honey bees. Three major polypeptides                  response ABPV infection &#226;&#8364;&#8220; contrast reaction <br /> detected early infected cells, corresponding capsid      observed challenge E. coli. ABPV-infected indi- <br /> proteins viral precursor protein (VP0) possibly       viduals did produce elevated levels specific AMPs <br /> consisted VP2 VP4 [36, 37] analogous VP1/VP4             hymenoptaecin, did detect general <br /> expressed bee larvae adults (Figs. 2, 3).                   antimicrobial activity inhibition-zone assay (Fig. 4). <br />     Newly synthesized ABPV capsid proteins clearly            Expression hymenoptaecin bees mediated Imd <br /> visible haemolymph infected bee larvae adults         signalling cascade, revealed RNA interference studies <br /> between 9 12 h p.i., increased rapidly        [47]. Hence, absence hymenoptaecin ABPV- <br /> up 24 h p.i. (Figs. 2A, 3A). The haemolymph contains            infected cells implies Imd pathway initiating a <br /> several types cells, called haemocytes, differ var-     humoral immune response induced ABPV <br /> ious insects [50]. However, prevalent cell type         infection. These results consistent studies carried <br /> insects plasmatocytes, partially responsible     Sabatier et al. [43] Costa et al. [15], did not <br /> phagocytosis invading pathogens [28, 33]. Although           detect known AMPs haemolymph Dro- <br /> cannot completely rule ABPV propagated fat      sophila flies challenged DCV CrPV (two members of <br /> body tissue subsequently released        family Dicistroviridae), supporting finding viral <br /> haemocoel, think likely ABPV multiplies         infections insects induce innate immune <br /> free haemocytes. This assumption supported               response bacterial infections. As mentioned above, the <br /> observation ABPV capsid proteins (VP0, VP2 VP3)           intrinsic defence mechanism based RNA interference <br /> were highly enriched cellular fraction low-speed      plays major role antiviral immunity insects. Future <br /> centrifugation (*15,000 g) total haemolymph         studies utmost importance reveal role RNAi in <br /> in supernatant. In contrast, AMPs immune-respon-           antiviral response honey bees. <br /> sive proteins produced fat body challenge           The failure detect AMPs virus-infected individuals <br /> bacteria enriched supernatant fraction (not      actually mean humoral immune responses are <br /> shown). Moreover, noted observed         suppressed virus. To address question, have <br /> the occurrence ABPV-specific capsid precursor VP0           carried numerous experiments simultaneous <br /> (composed VP1 VP4) simultaneously capsid               injections E. coli ABPV larvae adult bees <br /> units VP2 VP3 haemolymph infected larvae         (Fig. 6). We observed mutual detrimental effects mixed <br />  <br />  <br /> 123 <br />  Immune response acute bee paralysis virus                                                                                                  701 <br />  <br />  <br /> infections levels, i.e., expression antimi-                 2. Allen M, Ball B (1996) The incidence world distribution of <br /> crobial peptides onset extent ABPV                      honey bee viruses. Bee World 77:141&#226;&#8364;&#8220;162 <br />                                                                            3. Arjona A, Wang P, Montgomery RR, Fikrig E (2011) Innate <br /> propagation. The impact response dependent                      immune control West Nile virus infection. Cell Microbiol. doi: <br /> to degree injected individual dose E. coli                     10.1111/j.1462-5822.2011.01649.x <br /> cells ABPV particles mixed infections. But                       4. Bailey L, Milne RG (1969) The multiplication regions and <br /> detected antimicrobial activities specific AMPs                    interaction acute chronic bee-paralysis viruses adult <br />                                                                               honey bees. J Gen Virol 4:9&#226;&#8364;&#8220;14 <br /> haemolymph individuals challenged types                    5. Bailey L, Gibbs AJ, Woods RD (1963) Two viruses adult <br /> pathogens, indicating strong humoral immune                          honey bees (Apis mellifera Linnaeus). Virology 21:390&#226;&#8364;&#8220;395 <br /> response induced bacterial challenge suppressed               6. Ball BV (1985) Acute paralysis virus isolates honeybee <br /> completely viral infection (Fig. 6).                                       colonies infested Varroa jacobsoni. J Apic Res 24:115&#226;&#8364;&#8220;119 <br />                                                                            7. Bakonyi T, Grabensteiner E, Kolodziejek J, Rusvai M, Topolska <br />     The high yield ABPV particles produced                     G, Ritter W, Nowotny N (2002) Phylogenetic analysis Acute <br /> first 12 h p.i. bee larvae adults clearly precedes                 bee paralysis virus strains. Appl Environ Microbiol 68:6446&#226;&#8364;&#8220;6450 <br /> noticeable responses infected individuals             8. Bedick JC, Tunaz H, Nor Aliza AR, Putnam SM, Ellis MD, <br /> molecular level occurrence pathological symp-                    Stanley DW (2001) Eicosanoids act nodulation reactions to <br />                                                                               bacterial infections newly emerged adult honey bees, Apis <br /> toms: overall haemolymph protein pattern remained                         mellifera, older foragers. Comp Biochem Physiol Part <br /> essentially unchanged early infection period,                     C 130:107&#226;&#8364;&#8220;117 <br /> pathological effects visible (Figs. 2, 3).               9. Bonning BC, Miller WA (2010) Dicistroviruses. Annu Rev <br /> Later on, responses sick bee larvae adults differed                Entomol 55:129&#226;&#8364;&#8220;150 <br />                                                                           10. Bu&#194;&#168;yu&#194;&#168;kgu&#194;&#168;zel E, Tunaz H, Stanley D, Bu&#194;&#168;yu&#194;&#168;kgu&#194;&#168;zel K (2007) <br /> strikingly. Protein analysis haemolymph samples col-                       Eicosanoids mediate Galleria mellonella cellular immune <br /> lected ABPV-infected adult bees revealed major                        response viral infection. J Insect Physiol 53:99&#226;&#8364;&#8220;105 <br /> alterations entire infection process&#226;&#8364;&#8221;apart                 11. Casteels-Josson K, Zhang W, Capaci T, Casteels P, Tempst P <br /> from massive synthesis ABPV capsid proteins                            (1994) Acute transcriptional response honeybee peptide- <br />                                                                               antibiotics gene repertoire required post-translational <br /> (Fig. 2A), haemolymph ABPV-infected                         conversion precursor structures. J Biol Chem 269:28569&#226;&#8364;&#8220; <br /> larvae broad spectrum proteins induced 12                    28575 <br /> and 24 h p.i., included various heat-shock proteins                 12. Cerenius L, Lee BL, So&#194;&#168;derhall K (2008) The proPO-system: pros <br /> (Table S1). Finally, major larva-specific haemolymph                      cons role invertebrate immunity. Trends Immunol <br />                                                                               29:263&#226;&#8364;&#8220;271 <br /> proteins hexamerins 70a 70b degraded                     13. Chen YP, Siede R (2007) Honey bee viruses. Adv Virus Res <br /> (Fig. 3A; Table S1). The impressive change haemo-                      70:33&#226;&#8364;&#8220;80 <br /> lymph protein pattern coincided dramatic change                 14. Christian P, Carstens E, Domier L, Johnson J, Johnson K, <br /> the appearance ABPV-infected bee larvae (Fig. 3C). The                     Nakashima N, Scotti P, van der Wilk F (2005) Dicistroviridae. In: <br />                                                                               Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA <br /> quick simultaneous deadly collapse bee larvae                   (eds) Virus Taxonomy VIII. Elsevier Academic Press, San Diego, <br /> upon ABPV infection combined striking features                     pp 783&#226;&#8364;&#8220;788 <br /> indicate vitro-cultured bee larvae convenient                 15. Costa A, Jan E, Sarnow P, Schneider D (2009) The Imd pathway <br /> model organisms (i) reliable quick bioassays test                  involved antiviral immune responses Drosophila. PLoS <br />                                                                               One. doi:10.1371/journal.pone.0007436 <br /> ABPV infectivity, (ii) study host-virus interactions,              16. Deddouche S, Matt N, Budd A, Mueller S, Kemp C, Galiana- <br /> and (iii) screening antiviral compounds [22].                          Arnoux D, Dostert C, Antoniewski C, Hoffmann JA, Imler J-L <br />                                                                               (2008) The DExD/H-box helicase Dicer-2 mediates induction <br /> Acknowledgments We thank D. Ahrens-Lagast (BEEgroup, Wu&#194;&#168;rz-                   antiviral activity drosophila. Nat Immunol 9:1425&#226;&#8364;&#8220;1432 <br /> burg) excellent management bee colonies. We grateful    17. Miranda JR, Drebot M, Tyler S, Shen M, Cameron CE, Stoltz <br /> Professor H. J. Gross (University Wu&#194;&#168;rzburg) critical reading       DB, Camazine SM (2004) Complete nucleotide sequence of <br /> the manuscript. This project financially supported grant        Kashmir bee virus comparison acute bee paralysis virus. <br /> the &#226;&#8364;&#732;&#226;&#8364;&#732;Deutsche Forschungsgemeinschaft&#226;&#8364;&#8482;&#226;&#8364;&#8482;, SFB 567, Part A9.                    J Gen Virol 85:2263&#226;&#8364;&#8220;2270 <br />                                                                           18. Miranda JR, Cordoni G, Budge G (2010) The Acute bee <br /> Open Access This article distributed terms                paralysis virus-Kashmir bee virus-Israeli acute paralysis virus <br /> Creative Commons Attribution Noncommercial License per-                 complex. J Invertebr Pathol 103:S30&#226;&#8364;&#8220;S47 <br /> mits noncommercial use, distribution, reproduction         19. Dostert C, Jouanguy E, Irving P, Troxler L, Galiana-Arnoux D, <br /> medium, provided original author(s) source credited.              Hetru C, Hoffmann JA, Imler J-L (2005) The Jak-STAT signaling <br />                                                                               pathway required sufficient antiviral response of <br />                                                                               drosophila. Nat Immunol 6:946&#226;&#8364;&#8220;953 <br />                                                                           20. Durmus&#194;&#184; Y, Bu&#194;&#168;yu&#194;&#168;kgu&#194;&#168;zel E, Terzi B, Tunaz H, Stanley D, <br />                                                                               Bu&#194;&#168;yu&#194;&#168;kgu&#194;&#168;zel K (2008) Eicosanoids mediate melanotic nodulation <br /> References                                                                    reactions viral infection larvae parasitic wasp, Pimpla <br />                                                                               turionellae. J Insect Physiol 54:17&#226;&#8364;&#8220;24 <br />  1. Albert S, Ga&#194;&#168;tschenberger H, Azzami K, Gimple O, Grimmer G,           21. Evans JD, Aronstein K, Chen YP, Hetru C, Imler J-L, Jiang M, <br />     Sumner S, Fujiyuki T, Tautz J, Mueller MJ (2011) Evidence            Kanost M, Thompson GJ, Zou Z, Hultmark D (2006) Immune <br />     novel immune responsive protein Hymenoptera. Insect                pathways defence mechanisms honey bees Apis mellifera. <br />     Biochem Mol Biol 41:968&#226;&#8364;&#8220;981                                               Insect Mol Biol 15:645&#226;&#8364;&#8220;656 <br />  <br />  <br />                                                                                                                                       123 <br />  702                                                                                                                               K. Azzami et al. <br />  <br /> 22. Fedorova AA, Azzami K, Ryabchikova EI, Spitsyna YE, Silnikov           40. Peng Y-SC, Mussen E, Fong A, Montague MA, Tyler T (1992) <br />     VN, Ritter W, Gross HJ, Tautz J, Vlassov VV, Beier H, Zenkova              Effects chlortetracycline honey bee worker larvae reared <br />     MA (2011) Inactivation non-enveloped RNA virus arti-               vitro. J Invertebr Pathol 60:127&#226;&#8364;&#8220;133 <br />     ficial ribonucleases: honey bees Acute bee paralysis virus      41. Randolt K, Gimple O, Geissendo&#194;&#168;rfer J, Reinders J, Prusko C, <br />     new experimental model vivo antiviral activity assess-            Mueller MJ, Albert S, Tautz J, Beier H (2008) Immune-related <br />     ment. Antiviral Res 91:267&#226;&#8364;&#8220;277                                             proteins induced hemolymph aseptic septic injury <br /> 23. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA,                    differ honey bee worker larvae adults. Arch Insect Bio- <br />     Imler J-L (2006) Essential function vivo Dicer-2 host            chem Physiol 69:155&#226;&#8364;&#8220;167 <br />     defense RNA viruses drosophila. Nat Immunol                 42. Ryan MD, Flint M (1997) Virus-encoded proteinases the <br />     7:590&#226;&#8364;&#8220;597                                                                  picornavirus super-group. J Gen Virol 78:699&#226;&#8364;&#8220;723 <br /> 24. Genersch E, Aubert M (2010) Emerging re-emerging viruses           43. Sabatier L, Jouanguy E, Dostert C, Zachary D, Dimarcq J-L, <br />     honey bee (Apis mellifera L.). Vet Res 41:54                        Bulet P, Imler J-L (2003) Pherokine-2 -3: Drosophila <br /> 25. Govan VA, Leat N, Allsopp M, Davison S (2000) Analysis              molecules related pheromone/odor-binding proteins induced <br />     complete genome sequence Acute bee paralysis virus shows                viral bacterial infections. Eur J Biochem 270:3398&#226;&#8364;&#8220;3407 <br />     belongs novel group insect-infecting RNA viruses.    44. Sa&#194;&#180;nchez-Vargas I, Scott JC, Poole-Smith BK, Franz AWE, Barb- <br />     Virology 277:457&#226;&#8364;&#8220;463                                                       osa-Solomieu V, Wilusz J, Olson KE, Blair CD (2009) Dengue <br /> 26. Honeybee Genome Sequencing Consortium (2006) Insights                 virus type 2 infections Aedes aegypti modulated the <br />     social insects genome honeybee Apis mellifera.             mosquito&#226;&#8364;&#8482;s <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span>RNA interference pathway</span>. PLoS Pathog 5:e1000299 <br />     Nature 443:931&#226;&#8364;&#8220;949                                                     45. Sasaki J, Nakashima N, Saito H, Noda H (1998) An insect pic- <br /> 27. Horohov DW, Dunn PE (1983) Phagocytosis nodule forma-                  orna-like virus, Plautia stali intestine virus, genes capsid <br />     tion hemocytes Manduca sexta larvae following injection           proteins 30 genome. Virology 244:50&#226;&#8364;&#8220;58 <br />     Pseudomonas aeruginosa. J Invertebr Pathol 41:203&#226;&#8364;&#8220;213                  46. Scha&#194;&#168;gger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate- <br /> 28. Hultmark D (2003) Drosophila immunity: paths patterns.                 polyacrylamide gel electrophoresis separation proteins <br />     Curr Opin Immunol 15:12&#226;&#8364;&#8220;19                                                 range 1 100 kDa. Anal Biochem 166:368&#226;&#8364;&#8220;379 <br /> 29. Huszar T, Imler J-L (2008) Drosophila viruses study         47. Schlu&#194;&#168;ns H, Crozier RH (2007) Relish regulates expression of <br />     antiviral host-defense. Adv Virus Res 72:227&#226;&#8364;&#8220;265                           antimicrobial peptide genes honeybee, Apis mellifera, <br /> 30. Kieft JS (2009) Comparing three-dimensional structures              shown RNA interference. Insect Mol Biol 16:753&#226;&#8364;&#8220;759 <br />     Dicistroviridae IGR IRES RNAs RNA structures.               48. Stanley DW, Miller JS (2006) Eicosanoid actions insect cel- <br />     Virus Res 139:148&#226;&#8364;&#8220;156                                                      lular immune functions. Entomol Exp Appl 119:1&#226;&#8364;&#8220;13 <br /> 31. Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ,               49. Tate J, Liljas L, Scotti P, Christian P, Lin T, Johnson JE (1999) <br />     Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S,                    The crystal structure cricket paralysis virus: view a <br />     Anderson CW, Wimmer E (1981) Primary structure, gene orga-                 new virus family. Nat Struct Mol Biol 6:765&#226;&#8364;&#8220;774 <br />     nization polypeptide expression poliovirus RNA. Nature          50. Trenczek T (1998) Endogenous defense mechanisms insects. <br />     291:547&#226;&#8364;&#8220;553                                                                Zoology 101:298&#226;&#8364;&#8220;315 <br /> 32. Laemmli UK (1970) Cleavage structural proteins           51. Ulvila J, Hultmark D, Ra&#194;&#168;met M (2010) RNA silencing the <br />     assembly head bacteriophage T4. Nature 227:680&#226;&#8364;&#8220;685               antiviral innate immune defence-Role DEAD-box RNA heli- <br /> 33. Lemaitre B, Hoffmann J (2007) The host defense Drosophila               cases. Scand J Immunol 71:146&#226;&#8364;&#8220;158 <br />     melanogaster. Annu Rev Immunol 25:697&#226;&#8364;&#8220;743                              52. van Munster M, Dullemanns AM, Verbeek M, van den Heuvel <br /> 34. Liljas L, Tate J, Lin T, Christian P, Johnson JE (2002) Evolu-             JFJM, Cle&#194;&#180;rivet A, van der Wilk F (2002) Sequence analysis and <br />     tionary taxonomic implications conserved structural motifs          genomic organization Aphid lethal paralysis virus: new <br />     picornaviruses insect picorna-like viruses. Arch               member family Dicistroviridae. J Gen Virol 83:3131&#226;&#8364;&#8220;3138 <br />     Virol 147:59&#226;&#8364;&#8220;84                                                        53. van Rij RP, Saleh M-C, Berry B, Foo C, Houk A, Antoniewski C, <br /> 35. Maori E, Lavi S, Mozes-Koch R, Gantman Y, Peretz Y,                        Andino R (2006) The RNA silencing endonuclease Argonaute 2 <br />     Edelbaum O, Tanne E, Sela I (2007) Isolation characteriza-             mediates specific antiviral immunity Drosophila melanogaster. <br />     tion Israeli acute paralysis virus, dicistrovirus affecting           Genes Dev 20:2985&#226;&#8364;&#8220;2995 <br />     honeybees Israel: evidence diversity intra- inter-   54. Wang X-H, Aliyari R, Li W-X, Li H-W, Kim K, Carthew R, <br />     species recombination. J Gen Virol 88:3428&#226;&#8364;&#8220;3438                            Atkinson P, Ding S-W (2006) RNA interference directs inn <br /> </body></html>